We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$1.18M
AUM Growth
-$1.05B
Cap. Flow
-$403M
Cap. Flow %
-34,025.24%
Top 10 Hldgs %
51.44%
Holding
164
New
55
Increased
4
Reduced
8
Closed
25

Top Buys

Rank Stock Value
1
BGC icon
BGC Group
BGC
+$27.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$16.1M
3
JXN icon
Jackson Financial
JXN
+$12M
4
AAMI
Acadian Asset Management
AAMI
+$7.05M
5
WQGA.U
World Quantum Growth Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant to acquire one Class A ordinary share
WQGA.U
+$5M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$115M
2
WORK
Slack Technologies, Inc.
WORK
+$86.8M
3
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$73.7M
4
BABA icon
Alibaba
BABA
+$72.9M
5
WTW icon
Willis Towers Watson
WTW
+$53.2M

Sector Composition

Rank Sector Weight
1 Financials 11.54%
2 Consumer Discretionary 7.69%
3 Healthcare 5.6%
4 Industrials 5.14%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPE
126
DELISTED
SC Health Corporation
SCPE
– –
-400,000
Closed -$4.03M
RTP.WS
127
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
– –
-125,000
Closed -$246K
BPY
128
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
– –
-3,860,533
Closed -$73.7M
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-624,427
Closed -$115M
WORK
130
DELISTED
Slack Technologies, Inc.
WORK
– –
-1,945,702
Closed -$86.8M
WPF.WS
131
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
– –
-200,000
Closed -$426K
CCX.WS
132
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
– –
-66,666
Closed -$153K
2 3 4 5
6

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return

Boussard & Gavaudan Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Boussard & Gavaudan Investment Management held 164 positions worth $1.18M, down 100% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $403M in Q3 2021, closing 25 positions and reducing 8 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in BGC Group worth $27.3K.

  • Boussard & Gavaudan Investment Management's largest Q3 2021 buy was BGC Group: 5,236,279 shares worth $27.3K.
  • Boussard & Gavaudan Investment Management added most to Octave Specialty Group in Q3 2021, an estimated $3.11M increase.
  • Boussard & Gavaudan Investment Management's biggest Q3 2021 reduction was Alibaba, cutting an estimated $72.9M.
  • Boussard & Gavaudan Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $115M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 51% of its $1.18M portfolio in Q3 2021.
  • Boussard & Gavaudan Investment Management opened 55 new positions and closed 25 in Q3 2021.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $1.18M.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2021, filed 8 Nov 2021.